Corti Therapeutics
- Biotech or pharma, therapeutic R&D
Corti therapeutics is developing a leading LNP technology for mRNA delivery. The technology features (1) durable protein expression in vivo; (2) active targeting extrahepatic tissues without the complex antibody conjugation; (3) balanced key properties including potency, safety, redosability and developability.
Corti is developing mRNA/LNP based in-life protein therapies with initial indications in immune disorders and cardiovascular diseases.
Corti is open to partnership in the LNP technology and the pipeline assets.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}